T3	Treatment 0 9	Tenofovir
T5	Effect 21 35	nephrotoxicity
T6	Subject 39 72	two HIV-infected adolescent males
T8	Population 39 42	two
T9	Age 56 66	adolescent
T10	Gender 67 72	males
T11	Drug 0 9	Tenofovir
T12	Treat-Disorder 43 55	HIV-infected
T4	Adverse_event 10 20	associated
E1	Adverse_event:T4